11,28,000 Equity Shares allotted pursuant to conversion of warrants

Shelter Pharma Ltd has allotted 11,28,000 equity shares after certain warrant holders opted to convert their warrants into shares. These warrants were originally issued on August 6, 2025, as part of a preferential allotment of 88,08,000 convertible warrants at ₹42.25 per warrant. The warrant holders paid the remaining 75% of the issue price (₹31.6875 per share), bringing in ₹3.57 crore to the company. Both promoter group members and non-promoters participated in this conversion (5 investors in total, of which 2 are from the promoter group). As a result, the company's paid-up share capital has increased from 1,28,73,792 shares to 1,40,01,792 shares, an increase of about 8.76%.